Daptomycin Injection — FDA Drug Shortage

To Be Discontinued — Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)

The FDA lists a drug shortage record for Daptomycin Injection (injection) from Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.) with status To Be Discontinued. The shortage was first posted on Jun 30, 2026.

Shortage details

Status
To Be Discontinued
Company
Jiangsu Hengrui Pharmaceuticals Co. (US Agent eVenus Pharmaceutical Laboratories, Inc.)
Package NDC
57884-3151-1
Dosage Form
Injection
Presentation
Daptomycin, Injection, 500 mg/10 mL (NDC 57884-3151-1)
Initial Posting
Jun 30, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.